Excellent outcomes have been achieved in the field of renal transplantation. A significant
reduction in acute rejection has been attained at many renal transplant centers using …

Introduction Preferences for the testing and treatment of antibody‐mediated rejection (AMR)
in renal transplant patients vary among programs and individual practitioners. The …

Although acute renal graft rejection rate has declined in the last years, and because an
adequate therapy can improve graft outcome, its therapy remains as one of the most …

Donor-specific antibodies (DSAs) are major mediators of renal allograft injury, and strategies
to inhibit DSAs are important in promoting long-term graft survival. Triptolide exhibits a wide …

Kidney transplant is the preferred treatment of pediatric end-stage renal disease. One of the
most challenging aspects of pediatric kidney transplant is the prevention and treatment of …

Antibody mediated rejection (ABMR) is a major cause of heart transplant failure, there is
currently few effective treatments. Zanubrutinib is a Bruton tyrosine kinase (BTK) inhibitor …